![3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate](https://www.pudeepharm.com/wp-content/uploads/2021/03/641569-96-2.gif)
Product Description
Nilotinib is for treating of leukemia resistant to imatinib. 3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate is a key intermediate of Nilotinib. Its Appearance is white crystalline powder. Assay (HPLC) 99.% +, COA , MOA, HPLC and NMR are available. The minimum order quantity is 500 g. Packing size : 500g/bag, 1kg/bag, 10kg/drum, 25kg/drum.
![1138028-44-0,(Z)-2-((Z)-2-((((((1R,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methyl)sulfonyl)oxy)imino)thiophen-3(2H)-ylidene)-2-(o-tolyl)acetonitrile](https://www.pudeepharm.com/wp-content/uploads/2025/12/400.jpg)
![2376639-48-2,Ethanesulfonicacid,1,1,2,2-tetrafluoro-2-(1,1,2,2-tetrafluoro-4-tricyclo[3.3.1.13,7]dec-1-ylbutoxy)-](https://www.pudeepharm.com/wp-content/uploads/2025/12/482.jpg)
![1383380-44-6,[1]Benzothieno[3,2-b][1]benzothiophene, 3,8-dibromo-](https://www.pudeepharm.com/wp-content/uploads/2025/12/446.jpg)
![1202575-36-7,3-Ethoxy-3-[4-(2-methyl-benzyloxy)-phenyl]-propionic acid](https://www.pudeepharm.com/wp-content/uploads/2025/12/3677.jpg)